top of page

Rimegepant: Effective Migraine Relief for Triptan-Unsuitable Adults
A new study published in Cephalalgia explores the effectiveness of rimegepant for individuals with migraines who cannot use triptans. In this phase 4 ...

MigraineMind
Nov 20, 20251 min read
Rimegepant: A New Hope for Preventing Episodic Migraines
A recent study published in the journal Cephalalgia explored the effectiveness of rimegepant in preventing episodic migraines for adults who had previ...

MigraineMind
Nov 20, 20251 min read
Migraine Burden Rising: Insights from China and Global Trends
A recent study published in Frontiers in Neurology delves into the rising burden of migraines in China and across the globe from 1990 to 2021. Analyzi...

MigraineMind
Nov 20, 20251 min read
Migraine Cases Surge by 58% Globally: New Study Insights
A recent study published in Frontiers in Neurology examines the global and regional burden of migraines from 1990 to 2021, using data from the Global ...

MigraineMind
Nov 20, 20251 min read
Neurological Changes in Chronic Migraine: New Insights
A recent study published in the Journal of Headache and Pain explores the changes in the brain associated with chronic migraines. Researchers focused ...

MigraineMind
Nov 20, 20251 min read
Lactylation's Role in Migraines: New Insights Revealed
A recent study published in the Journal of Headache and Pain explores the emerging role of lactylation in migraine pathophysiology, focusing on its in...

MigraineMind
Nov 20, 20251 min read
Standardizing Migraine Treatment: Nova Scotia's Prescribing Gaps
A new study published in the Canadian Journal of Neurological Sciences explores how primary care providers in Nova Scotia manage migraines pharmacolog...

MigraineMind
Nov 20, 20251 min read
bottom of page